Q1 2025 Earnings Call Transcript May 9, 2025 Ocugen, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations ...

Operator: Good day and welcome to the First Quarter 2025 FTAI Infrastructure Earnings Conference Call. At this time, all ...

Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing well and on target for potential BLA/MAA filings by mid-2026Anticipate init ...

With the 2025 legislative session in the rearview mirror, North Dakotans can expect to save money on property taxes and ...

It could improve access to community pharmacies and lower prices. Or it will limit access to critical drugs and impact payers’ ability to contract for a broad range of services. Industry leaders are ...

Welcome to this month’s issue of The BR Privacy & Security Download, the digital newsletter of Blank Rome’s Privacy, Security, & Data ...

Rep. John Ley reports on serious concerns with the I-5 Bridge replacement project, including limited contractor interest, ...